Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.
Read more about our recent #EuropeanFairPricingNetwork study from the @eurcorrespond.bsky.social ⤵️
Read more about our recent #EuropeanFairPricingNetwork study from the @eurcorrespond.bsky.social ⤵️
Life-saving medicine, secret prices
Imagine you're in charge of cancer medicine procurement at a hospital. It's a big responsibility, as the medication not only saves lives, but is also
europeancorrespondent.com
March 31, 2026 at 7:53 AM
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.
Read more about our recent #EuropeanFairPricingNetwork study from the @eurcorrespond.bsky.social ⤵️
Read more about our recent #EuropeanFairPricingNetwork study from the @eurcorrespond.bsky.social ⤵️
🚨 New #EuropeanFairPricingNetwork research shows that some hospitals pay more than double for the exact same cancer drug.
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.
🔗 buff.ly/t7VKfrT
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.
🔗 buff.ly/t7VKfrT
March 11, 2026 at 10:10 AM
🚨 New #EuropeanFairPricingNetwork research shows that some hospitals pay more than double for the exact same cancer drug.
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.
🔗 buff.ly/t7VKfrT
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU.
🔗 buff.ly/t7VKfrT
New #EuropeanFairPricingNetwork research shows that some hospitals pay more than double for the exact same cancer drug.
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU ➡️ www.nki.nl/news-events/...
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU ➡️ www.nki.nl/news-events/...
March 11, 2026 at 5:00 AM
New #EuropeanFairPricingNetwork research shows that some hospitals pay more than double for the exact same cancer drug.
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU ➡️ www.nki.nl/news-events/...
Confidential price negotiations are leaving hospitals in the dark, weaking their bargaining power and deepening inequalities across the EU ➡️ www.nki.nl/news-events/...
Cancer is pushing many patients in Europe in financial dire straits – even in countries with strong healthcare systems.
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis ➡️ www.nki.nl/news-events/...
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis ➡️ www.nki.nl/news-events/...
July 1, 2025 at 9:20 AM
Cancer is pushing many patients in Europe in financial dire straits – even in countries with strong healthcare systems.
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis ➡️ www.nki.nl/news-events/...
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis ➡️ www.nki.nl/news-events/...
💶🤝 Together with the #EuropeanFairPricingNetwork, we call for fair prices for cancer medicines and a pharmaceutical market which puts patients first.
Learn more about this initiative from ECL, @nkinl.bsky.social, @komoptegenkanker.bsky.social, @krebsliga.bsky.social, and many others: www.efpn.eu
Learn more about this initiative from ECL, @nkinl.bsky.social, @komoptegenkanker.bsky.social, @krebsliga.bsky.social, and many others: www.efpn.eu
June 30, 2025 at 9:32 AM
💶🤝 Together with the #EuropeanFairPricingNetwork, we call for fair prices for cancer medicines and a pharmaceutical market which puts patients first.
Learn more about this initiative from ECL, @nkinl.bsky.social, @komoptegenkanker.bsky.social, @krebsliga.bsky.social, and many others: www.efpn.eu
Learn more about this initiative from ECL, @nkinl.bsky.social, @komoptegenkanker.bsky.social, @krebsliga.bsky.social, and many others: www.efpn.eu
The results, based on a survey of more than 2,500 cancer patients across 25 European countries, are a cause for concern:
💰 56% lost income
💰 28% saw their income drop with up to €800/month
💰 86% faced extra costs & 16% delayed or skipped care
#EuropeanFairPricingNetwork
💰 56% lost income
💰 28% saw their income drop with up to €800/month
💰 86% faced extra costs & 16% delayed or skipped care
#EuropeanFairPricingNetwork
June 30, 2025 at 9:32 AM
The results, based on a survey of more than 2,500 cancer patients across 25 European countries, are a cause for concern:
💰 56% lost income
💰 28% saw their income drop with up to €800/month
💰 86% faced extra costs & 16% delayed or skipped care
#EuropeanFairPricingNetwork
💰 56% lost income
💰 28% saw their income drop with up to €800/month
💰 86% faced extra costs & 16% delayed or skipped care
#EuropeanFairPricingNetwork
Cancer is pushing many patients in Europe in financial dire straits – even in countries with strong healthcare systems.
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis.
🔗 buff.ly/3XipCCz
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis.
🔗 buff.ly/3XipCCz
June 30, 2025 at 9:31 AM
Cancer is pushing many patients in Europe in financial dire straits – even in countries with strong healthcare systems.
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis.
🔗 buff.ly/3XipCCz
A new #EuropeanFairPricingNetwork study shows that patients lose income, face additional costs & skip care after diagnosis.
🔗 buff.ly/3XipCCz